FDA Cites Poor Manufacturing Processes in Supplements Seizure

"This seizure underscores the agency's commitment to taking aggressive action when manufacturers distribute adulterated dietary supplements that have the potential to put consumers at risk," said Melinda K. Plaisier, FDA's associate commissioner for Regulatory Affairs.

The U.S. Food and Drug Administration recently announced that at its request, U.S. marshals seized more than 300,000 containers of dietary supplements, including tablets, capsules, and teas, from Life Rising Corporation. The seized goods, which were held by Life Rising or manufactured in the company's facility in Willowbrook, Ill., consisted of more than 500 products bearing brand names Life Rising, Holicare, or HopeStream and are valued at approximately $3.5 million. The U.S. district court for the Northern District of Illinois determined there was probable cause that the company prepared, packed, and/or held dietary supplements under conditions that do not conform to the dietary supplement current good manufacturing practice requirements, FDA reported.

"This seizure underscores the agency's commitment to taking aggressive action when manufacturers distribute adulterated dietary supplements that have the potential to put consumers at risk," said Melinda K. Plaisier, FDA's associate commissioner for Regulatory Affairs. "The FDA has a variety of enforcement tools at its disposal, and when products don't comply with FDA regulations, we will not hesitate to take appropriate action."

The agency reported that its inspection at Life Rising found that the company failed to establish product specifications for the identity, purity, strength, and composition of each finished batch of dietary supplement and for limits on certain types of contamination, to ensure the quality of the supplement. The company also lacked written procedures for pest control and for maintaining, cleaning, and sanitizing equipment and/or surfaces that came in contact with the dietary supplements, among other violations, FDA reported. Based on these CGMP violations, FDA issued an Administrative Detention Order to prevent the products from reaching consumers until they could be seized.

In May 2019, FDA also issued a safety alert for three Life Rising products (Life Rising Holder-W Holder Warmer capsules, Life Rising NECK-ND Neck Clear capsules, and HoliCare Metabolism Cleansing tablets) because those products may be contaminated with lead. These products were recalled by the company on May 2, a day before the safety alert was issued.

Download Center

HTML - No Current Item Deck
  • EHS Management Software Buyer's Guide

    Download this buyer's guide to make more informed decisions as you're looking for an EHS management software system for your organization.

  • Steps to Conduct a JSA

    We've put together a comprehensive step-by-step guide to help you perform a job safety analysis (JSA), which includes a pre-built, JSA checklist and template, steps of a JSA, list of potential job hazards, and an overview of hazard control hierarchy.

  • Levels of a Risk Matrix

    Risk matrices come in many different shapes and sizes. Understanding the components of a risk matrix will allow you and your organization to manage risk effectively.

  • Free Safety Management Software Demo

    IndustrySafe Safety Management Software helps organizations to improve safety by providing a comprehensive toolset of software modules to help businesses identify trouble spots; reduce claims, lost days, OSHA fines; and more.

  • Industry Safe
Bulwark FR Quiz

OH&S Digital Edition

  • OHS Magazine Digital Edition - March 2021

    March 2021

    Featuring:

    • EMPLOYEE TESTING
      The Impact of COVID-19 on Drug Testing
    • PROTECTIVE APPAREL
      Preparing for Unpredictable Spring Weather
    • FALL PROTECTION
      Building a Comprehensive Floor Safety Strategy
    • GAS DETECTION
      Gas Hazards and the COVID-19 Vaccine
    View This Issue